Found: 8
Select item for more details and to access through your institution.
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.
- Published in:
- EMBO Molecular Medicine, 2014, v. 6, n. 10, p. 1328, doi. 10.15252/emmm.201404112
- By:
- Publication type:
- Article
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.72512
- By:
- Publication type:
- Article
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4679, doi. 10.3390/cancers15194679
- By:
- Publication type:
- Article
Cover Image, Volume 43, Issue 5.
- Published in:
- Cancer Communications, 2023, v. 43, n. 5, p. i, doi. 10.1002/cac2.12442
- By:
- Publication type:
- Article
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer.
- Published in:
- Cancer Communications, 2023, v. 43, n. 5, p. 615, doi. 10.1002/cac2.12407
- By:
- Publication type:
- Article
Critical assessment of a proposed model of Shaker
- Published in:
- FEBS Letters, 2004, v. 564, n. 3, p. 257, doi. 10.1016/S0014-5793(04)00273-X
- By:
- Publication type:
- Article
Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01843-4
- By:
- Publication type:
- Article